Balyasny Asset Management
OKYO

Balyasny Asset Management’s OKYO Pharma OKYO Stock Holding History

Balyasny Asset Management’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$871K Sell
580,596
-4,200
-0.7% -$6.73K ﹤0.01% 2286
2026
Q1 		$942K Buy
+584,796
New +$1.14M ﹤0.01% 2102

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balyasny Asset Management's OKYO Position: Q2 2026 in Review

Balyasny Asset Management reduced its OKYO Pharma (OKYO) stake by 0.72% in Q2 2026, selling an estimated $6.73K and leaving 580,596 shares worth $871K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Balyasny Asset Management first reported a position in OKYO in Q1 2026 and has held it in 2 quarters since. The position peaked at $942K in Q1 2026. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Balyasny Asset Management held 580,596 shares of OKYO Pharma worth $871K as of Q2 2026.
  • Balyasny Asset Management sold 4,200 OKYO Pharma shares in Q2 2026, an estimated $6.73K.
  • OKYO Pharma made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2286 holding.
  • Balyasny Asset Management first reported a position in OKYO Pharma in Q1 2026 and has held it in 2 quarters since.
  • Balyasny Asset Management's OKYO Pharma position peaked at $942K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.